Metropolitan Life Insurance CO Frequency Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$8.05 - $11.61 $48 - $69	-6 Closed	0 $0
Q1 2021 Jun 26, 2023	BUY	$7.99 - $55.01 $44,352 - $305,360	5,551 New	5,551 $52.7 Million
Q1 2021 Mar 30, 2023	SELL	$7.99 - $55.01 $12,224 - $84,165	-1,530 Reduced 21.61%	5,551 $52,000
Q1 2021 May 14, 2021	SELL	$7.99 - $55.01 $56,529 - $389,195	-7,075 Reduced 99.92%	6 $53,000
Q4 2020 Jun 22, 2023	BUY	$18.65 - $40.0 $132,060 - $283,240	7,081 New	7,081 $249,000
Q4 2020 Mar 30, 2023	SELL	$18.65 - $40.0 $35,435 - $76,000	-1,900 Reduced 21.16%	7,081 $249,000
Q4 2020 Feb 16, 2021	SELL	$18.65 - $40.0 $35,435 - $76,000	-1,900 Reduced 21.16%	7,081 $250,000
Q3 2020 Jun 26, 2023	BUY	$17.76 - $24.96 $159,502 - $224,165	8,981 New	8,981 $172,000
Q2 2020 Jun 26, 2023	BUY	$14.65 - $24.9 $131,571 - $223,626	8,981 New	8,981 $208,000
Q2 2020 Mar 30, 2023	BUY	$14.65 - $24.9 $131,571 - $223,626	8,981 New	8,981 $208,000
Q2 2020 Aug 14, 2020	BUY	$14.65 - $24.9 $131,571 - $223,626	8,981 New	8,981 $209,000

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.